Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-5,028
Closed -$619K 171
2014
Q1
$619K Hold
5,028
0.21% 117
2013
Q4
$573K Hold
5,028
0.21% 113
2013
Q3
$563K Sell
5,028
-14
-0.3% -$1.52K 0.23% 113
2013
Q2
$497K Buy
+5,042
New +$523K 0.2% 116

Other funds holding AMGN

HHG & Company's AMGN Position: Q2 2014 in Review

HHG & Company sold out of Amgen (AMGN) in Q2 2014, closing a stake of 5,028 shares — an estimated $619K sold.

HHG & Company first reported a position in AMGN in Q2 2013 and held it in 4 quarters. The position peaked at $619K in Q1 2014. 1,185 funds tracked by Wall St. Rank hold AMGN as of Q2 2014.

  • HHG & Company reported no remaining Amgen position as of Q2 2014 after selling out during the quarter.
  • HHG & Company sold 5,028 Amgen shares in Q2 2014, an estimated $619K.
  • HHG & Company first reported a position in Amgen in Q2 2013 and held it in 4 quarters.
  • HHG & Company's Amgen position peaked at $619K in Q1 2014.
  • 1,185 funds tracked by Wall St. Rank held Amgen as of Q2 2014.

Based on HHG & Company's 13F filing for Q2 2014, filed 15 Aug 2014.